JP2004503248A - インフルエンザａウイルスおよび／またはインフルエンザｂウイルスの検出方法 - Google Patents

インフルエンザａウイルスおよび／またはインフルエンザｂウイルスの検出方法 Download PDF

Info

Publication number
JP2004503248A
JP2004503248A JP2002510708A JP2002510708A JP2004503248A JP 2004503248 A JP2004503248 A JP 2004503248A JP 2002510708 A JP2002510708 A JP 2002510708A JP 2002510708 A JP2002510708 A JP 2002510708A JP 2004503248 A JP2004503248 A JP 2004503248A
Authority
JP
Japan
Prior art keywords
influenza
virus
saliva
sample
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002510708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503248A5 (https=
Inventor
クレップ，ユルゲン
シュリップフェンバッヒル，ライナー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7645396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2004503248(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2004503248A publication Critical patent/JP2004503248A/ja
Publication of JP2004503248A5 publication Critical patent/JP2004503248A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2002510708A 2000-06-15 2001-06-15 インフルエンザａウイルスおよび／またはインフルエンザｂウイルスの検出方法 Pending JP2004503248A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10028837A DE10028837A1 (de) 2000-06-15 2000-06-15 Verfahren zum Nachweis von Influenza A/B-Viren
PCT/EP2001/006735 WO2001096595A2 (de) 2000-06-15 2001-06-15 Verfahren zum nachweis von influenza a/b-viren aus speichel

Publications (2)

Publication Number Publication Date
JP2004503248A true JP2004503248A (ja) 2004-02-05
JP2004503248A5 JP2004503248A5 (https=) 2005-02-03

Family

ID=7645396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510708A Pending JP2004503248A (ja) 2000-06-15 2001-06-15 インフルエンザａウイルスおよび／またはインフルエンザｂウイルスの検出方法

Country Status (9)

Country Link
US (1) US6811971B2 (https=)
EP (1) EP1297187B2 (https=)
JP (1) JP2004503248A (https=)
AT (1) ATE385259T1 (https=)
AU (1) AU2001278452A1 (https=)
CA (1) CA2412121C (https=)
DE (2) DE10028837A1 (https=)
ES (1) ES2298244T5 (https=)
WO (1) WO2001096595A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2535713A1 (en) 2011-06-16 2012-12-19 Fujifilm Corporation Highly sensitive immunochromatography method and immunochromatography kit
US12247950B2 (en) 2018-12-04 2025-03-11 Murata Manufacturing Co., Ltd. Virus detection system, virus detection method, and virus detection program

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275173A1 (en) * 2002-09-25 2004-04-19 Board Of Regents, The University Of Texas System Endogenous granzyme b in human non-hematopoietic cells
WO2006121773A2 (en) * 2005-05-06 2006-11-16 Gen-Probe Incorporated Compositions and assays to detect influenza virus a and b nucleic acids
AU2007217765A1 (en) * 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
US20080208486A1 (en) * 2006-03-23 2008-08-28 Jari Natunen Integrated System, Device and Use Thereof
US20070238095A1 (en) * 2006-04-11 2007-10-11 Mayo Foundation For Medical Education And Research , A Minnesota Corporation Detection of Influenza A Virus
US20070238093A1 (en) * 2006-04-11 2007-10-11 Espy Mark J Detection of influenza A virus
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
FI20060946A0 (fi) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
WO2008057605A2 (en) * 2006-11-10 2008-05-15 Quidel Corporation Nuclear protein extraction medium and method of use
WO2008128095A1 (en) * 2007-04-12 2008-10-23 Regents Of The University Of Minnesota Ischemia/reperfusion protection compositions and methods of using
EP2716656B1 (en) 2007-06-15 2016-10-12 Xiamen University Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
US9689031B2 (en) 2007-07-14 2017-06-27 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (en) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
US20110046001A1 (en) * 2007-11-20 2011-02-24 Autogenomics, Inc. Multiplex Assay for Respiratory Viruses
US8354230B2 (en) 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
JP2011523704A (ja) * 2008-05-20 2011-08-18 カンタイマー，インコーポレイティド イオン交換によって生体液試料を分析するための方法、システム、及び装置
US20110045458A1 (en) * 2009-08-20 2011-02-24 Mayo Foundation For Medical Education And Research Detection of Enterovirus
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
GB201703383D0 (en) 2017-03-02 2017-04-19 Gargle Tech Ltd Testing for particulates
EP4205851A3 (en) 2018-09-05 2023-10-04 Hero Scientific Ltd Testing for particulates
CN112204372A (zh) * 2018-11-08 2021-01-08 松下知识产权经营株式会社 检测系统以及信息显示系统
US11053531B2 (en) 2019-05-31 2021-07-06 Linda Marie Petter Tester paper and methods of use thereof for detecting a bacterial infection
US12449336B2 (en) 2020-03-11 2025-10-21 Hero Scientific Ltd. Testing devices
EP4165385B1 (en) 2021-01-06 2024-04-17 Hero Scientific Ltd Filtration sampling devices
US20240302370A1 (en) * 2021-02-12 2024-09-12 Siemens Healthcare Diagnostics Inc. Sample lysis reagent compositions and methods of production and use thereof
US12529707B2 (en) * 2021-07-22 2026-01-20 Assaya Llc Lateral flow assay machine testing quality verification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131504T2 (de) 1990-12-31 1999-11-18 Oklahoma Medical Research Foundation, Oklahoma Verfahren zum visuellen nachweis der anwesenheit eines virus in einer klinischen probe
FR2708348B1 (fr) 1993-07-28 1995-10-06 Stago Diagnostica Procédé de dosage d'une substance immunologique au moyen de particules de latex magnétiques et de particules non-magnétiques.
US5714341A (en) * 1994-03-30 1998-02-03 Epitope, Inc. Saliva assay method and device
US6015664A (en) 1995-11-03 2000-01-18 Mcw Research Foundation Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B
EP1010981A1 (de) 1998-12-18 2000-06-21 Diagor GmbH Konjugate zum Nachweis von Viren und deren Verwendung

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2535713A1 (en) 2011-06-16 2012-12-19 Fujifilm Corporation Highly sensitive immunochromatography method and immunochromatography kit
US8716032B2 (en) 2011-06-16 2014-05-06 Fujifilm Corporation Highly sensitive immunochromatography method and kit employing protein hydrolysates
US12247950B2 (en) 2018-12-04 2025-03-11 Murata Manufacturing Co., Ltd. Virus detection system, virus detection method, and virus detection program

Also Published As

Publication number Publication date
DE50113548D1 (de) 2008-03-20
WO2001096595A2 (de) 2001-12-20
EP1297187B2 (de) 2014-08-13
ES2298244T5 (es) 2014-11-14
DE10028837A1 (de) 2001-12-20
CA2412121A1 (en) 2002-12-09
US20030143530A1 (en) 2003-07-31
US6811971B2 (en) 2004-11-02
CA2412121C (en) 2009-09-01
EP1297187B1 (de) 2008-01-30
AU2001278452A1 (en) 2001-12-24
ES2298244T3 (es) 2008-05-16
EP1297187A2 (de) 2003-04-02
ATE385259T1 (de) 2008-02-15
WO2001096595A3 (de) 2002-05-23

Similar Documents

Publication Publication Date Title
CA2412121C (en) Method for the detection of influenza a/b viruses
EP4012050A1 (en) Composition, kit and method for detecting and typing viruses causing respiratory tract infection and application of composition, kit and method
Andréoletti et al. Differential detection of rhinoviruses and enteroviruses RNA sequences associated with classical immunofluorescence assay detection of respiratory virus antigens in nasopharyngeal swabs from infants with bronchiolitis
Mizuta et al. Analysis of monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in Yamagata, Japan
Afzal et al. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK
CN102337351A (zh) 一种流感病毒分型检测试剂盒
JP4950656B2 (ja) 核酸検出
Purohit et al. Sampling and analytical techniques for COVID-19
Billaud et al. Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR
CN104212914B (zh) 埃博拉五重荧光pcr快速超敏检测试剂盒及其应用
US20240094205A1 (en) Immunological test for the detection of viral infections
CN116334310A (zh) 一种甲型流感病毒核酸检测试剂、试剂盒及应用
Artik et al. General evaluation of COVID-19 diagnosis methods
Leparc et al. Search for poliovirus in specimens from patients with the post‐polio syndrome
Kumar et al. Analytical performances of different diagnostic methods for SARS-CoV-2 virus-A review
KR101987844B1 (ko) 호흡기 바이러스 검출을 위한 프라이머 세트 및 이의 용도
Valentova et al. Detection of Bovine Respiratory Syncytial Virus in Cell Cultures by nRT-PCR and Use of the Method for Virus Identification in Clinical Samples
CN106153926A (zh) 乙型脑炎病毒IgG抗体检测试剂盒及其制备方法
RU2850880C1 (ru) Набор олигонуклеотидных праймеров для выявления РНК вируса эпидемического паротита
Raytthatha et al. An Informative Review on screening of COVID-19 (SARS-COVID-II)
Jalowayski et al. Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children
Krumova et al. Monkeypox: Significance of Various Clinical Samples, Clinical Manifestation, and Molecular Genetic Analysis–Experience of Bulgaria
Kaore et al. Laboratory diagnosis of novel H1N1 virus
Sayed Ahmed Serodetection of Parvovirus B19 among pregnant women in Riyadh Saudi Arabia
Nyaruaba et al. Journal of Biosafety and Biosecurity

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060523

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080108